Marvel Biosciences is an agile, Calgary-based biotechnology company revolutionizing drug development by de-risking the (re)development of existing drugs to create novel therapeutics with enhanced efficacy and safety profiles. We capitalize on modifying known, off-patent drugs to deliver faster, safer, and more effective treatments. Our streamlined approach significantly reduces development costs, shortens timelines, and lowers risk compared to traditional biotech models.
Our lead compound has shown remarkable promise in preclinical studies, demonstrating efficacy for a wide range of conditions, including depression, anxiety, Alzheimer's disease, and autism. We are also actively investigating its potential in addressing other genetic disorders, such as Rett syndrome and Fragile X syndrome, further expanding our therapeutic reach. We have completed cGMP synthesis, toxicology studies, and preparation for Phase 1 clinical trials and are well-positioned to bring our groundbreaking solutions to market.
Company Details
- Employees
- 4
- Founded
- -
- Address
- 117 8 Ave Sw, 4th Floor,canada
- Industry
- Biotechnology
- HQ
- Calgary, Alberta
Marvel Biosciences Corp. Questions
Marvel Biosciences Corp.'s website is https://www.marvelbiotechnology.com
Marvel Biosciences Corp.'s LinkedIn profile is https://ca.linkedin.com/company/marvel-biotechnology
Marvel Biosciences Corp. has
4 employees.
View email and phone details for 4
employees at Marvel Biosciences Corp..
Marvel Biosciences Corp.'s industry is
Biotechnology
Marvel Biosciences Corp.'s top competitors are
Libra Therapeutics,
Grin Therapeutics, Inc.,
Dogwood Therapeutics,
Nuvie Bio,
Tenvie Therapeutics,
Alpha Cognition, Inc.,
Nervgen Pharma Corp.,
Vesper Bio,
Kariya Pharmaceuticals,
Neurolixis.
Marvel Biosciences Corp.'s categories are Biotechnology
Marvel Biosciences Corp.'s founding year is 2018
